Joseph Parkhurst, MD
Urology · Bethany, OKNPI 1205879772
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,447 of the $1,643 with a category attached, or 88.1%. It is spread thinly across 18 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $867 and has fallen 97.8% since, to $19 in 2025. That places this record below the midpoint for urology clinicians in OK, where the typical reported total is $3,895.
Across 43 payments — averaging $38.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$297
- Clarus Therapeutics Inc.$190
- Pfizer$169
- Astellas Pharma US Inc$168
- AbbVie$137
- Boston Scientific$135
- plus $547 from 12 others
What the payments were for
- Food & beverage$1,44788%
- Education$19512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 3 | $297 |
| Clarus Therapeutics Inc. | 5 | $190 |
| Pfizer | 4 | $169 |
| Astellas Pharma US Inc | 6 | $168 |
| AbbVie | 1 | $137 |
| Boston Scientific | 2 | $135 |
| Johnson & Johnson(2 entities) | 6 | $131 |
| AMAG Pharmaceuticals, Inc. | 1 | $115 |
| AstraZeneca | 1 | $78 |
| Neotract Inc. | 3 | $50 |
| Antares Pharma, Inc. | 3 | $46 |
| Endo Pharmaceuticals Inc. | 2 | $24 |
| Myovant Sciences Inc. | 1 | $24 |
| Medtronic | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Axonics, Inc. | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,643 in reported general payments places this provider in the 35th percentile of 145 urology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 56 | $1,316 |
| Finasteride | 20 | $343 |
Paid to pharmacies, not to this prescriber.
Other urology in Bethany
- Mohammad RamadanOklahoma City$207K
- Michael CooksonOklahoma City$132K
- Melanie KetchandjiTulsa$111K
- Kelly StrattonOklahoma City$62K
- Ashley BowenOklahoma City$32K
- Marc MilstenTulsa$29K
- Scott LitwillerTulsa$27K
- Sardar Mohammad Khan GalzieOklahoma City$25K
- Charles PritchardTulsa$23K
- Basel HassounOklahoma City$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.